Showing results (151-160 of 179) with videos related to
Sort By:
Pageof 18
BMC Endocrine Disorders|July 25, 2019
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and designRikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, et al.Diabetic Medicine : a Journal of the British Diabetic Association|October 2, 2025
A cohort description and comparison of four European national diabetes registries for the REDDIE projectJonah J C Thomas, Stefanie Lanzinger, Kathrine Kold Soerensen, et al.Diabetes Care|July 25, 2022
Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without DiabetesClementine E M Verhulst, Therese W Fabricius, Giesje Nefs, et al.Diabetes, Obesity & Metabolism|February 25, 2026
Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetesKathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini, et al.JMIR Diabetes|September 29, 2023
Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview StudyUffe Søholm, Natalie Zaremba, Melanie Broadley, et al.Diabetes, Obesity & Metabolism|March 20, 2024
The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta-analysisElisabeth J den Brok, Cecilie H Svensson, Maria Panagiotou, et al.Diabetologia|July 22, 2024
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trialsJoseph Mellor, Dmitry Kuznetsov, Simon Heller, et al.Diabetes, Obesity & Metabolism|May 19, 2026
Randomised Controlled Multicentre Trial to Investigate the Effectiveness of a Mobile Artificial Intelligence Solution for Diabetes Adapted Care: The MELISSA Trial ProtocolElisabeth J den Brok, Cecilie H Svensson, Mikkel T Olsen, et al.Cardiovascular Diabetology|October 7, 2025
Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetesKathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini, et al.BMJ Open|January 24, 2023
Behavioral factors associated with SARS-CoV-2 infectionMille Dybdal Bager, Florence Chia Chin Tan, Mogens Karsboel Boisen, et al.Pageof 18